Literature DB >> 22580675

Evaluation of mass-forming intrahepatic cholangiocarcinoma with viral hepatitis.

Kei Horino1, Toru Beppu, Hiroyuki Komori, Toshiro Masuda, Hiromitsu Hayashi, Hirohisa Okabe, Hiroshi Takamori, Hideo Baba.   

Abstract

BACKGROUND/AIMS: The correlation between the mass-forming type of intrahepatic cholangiocarcinoma (ICC) and the infection of the hepatitis B virus and hepatitis C virus are poorly understood. In this study, the clinical features of 34 patients with the mass-forming type ICC were reviewed to evaluate prognostic determinants.
METHODOLOGY: Between January 1997 and December 2007, 34 patients underwent surgical resection for the mass-forming type of ICC in Kumamoto University Hospital. The significance of 14 clinicopathological factors consisting of age, gender, CA19-9 levels, CEA levels, size, intrahepatic metastases, portal vein invasion, bile duct invasion, histological differentiation, lymph node involvement, type B or C hepatitis, lymph node dissection, Sirius Red score of the tumor and platelet count in peripheral blood were analyzed, with regard to prognostic aspect.
RESULTS: Univariate analysis showed that significant risk factors for poor survival included age =65 years, CEA levels =1.6ng/mL and pathological lymph node involvement. Multivariate analysis revealed that age, CEA levels and lymph node involvement were independent and significant poor prognostic factors.
CONCLUSIONS: It was concluded that age, CEA levels and lymph node involvement were significantly poor prognostic factors. However, the infection with type B or C hepatitis was not a prognostic factor of the mass forming type ICC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22580675     DOI: 10.5754/hge09739

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  4 in total

1.  Implications of Intrahepatic Cholangiocarcinoma Etiology on Recurrence and Prognosis after Curative-Intent Resection: a Multi-Institutional Study.

Authors:  Xu-Feng Zhang; Jeffery Chakedis; Fabio Bagante; Eliza W Beal; Yi Lv; Matthew Weiss; Irinel Popescu; Hugo P Marques; Luca Aldrighetti; Shishir K Maithel; Carlo Pulitano; Todd W Bauer; Feng Shen; George A Poultsides; Oliver Soubrane; Guillaume Martel; B Groot Koerkamp; Alfredo Guglielmi; Endo Itaru; Timothy M Pawlik
Journal:  World J Surg       Date:  2018-03       Impact factor: 3.352

Review 2.  Hepatitis B virus and hepatitis C virus play different prognostic roles in intrahepatic cholangiocarcinoma: A meta-analysis.

Authors:  Zheng Wang; Yuan-Yuan Sheng; Qiong-Zhu Dong; Lun-Xiu Qin
Journal:  World J Gastroenterol       Date:  2016-03-14       Impact factor: 5.742

3.  Surgical treatment of intrahepatic cholangiocarcinoma: a retrospective study of 104 cases.

Authors:  Xiao-Dong Xun; Qiang Li
Journal:  Cancer Biol Med       Date:  2016-12       Impact factor: 4.248

4.  Intrahepatic cholangiocarcinoma in the setting of HBV-related cirrhosis: Differentiation with hepatocellular carcinoma by using Intravoxel incoherent motion diffusion-weighted MR imaging.

Authors:  Yi Wei; Feifei Gao; Dandan Zheng; Zixing Huang; Min Wang; Fubi Hu; Chenyang Chen; Ting Duan; Jie Chen; Likun Cao; Bin Song
Journal:  Oncotarget       Date:  2017-12-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.